nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—CYP2D6—Temsirolimus—kidney cancer	0.202	0.323	CbGbCtD
Benzatropine—CYP2D6—Pazopanib—kidney cancer	0.106	0.17	CbGbCtD
Benzatropine—CYP2C19—Sorafenib—kidney cancer	0.0812	0.13	CbGbCtD
Benzatropine—CYP2D6—Erlotinib—kidney cancer	0.0759	0.121	CbGbCtD
Benzatropine—CYP2D6—Sorafenib—kidney cancer	0.0617	0.0986	CbGbCtD
Benzatropine—CYP2D6—Vinblastine—kidney cancer	0.0609	0.0973	CbGbCtD
Benzatropine—CYP2D6—Doxorubicin—kidney cancer	0.0374	0.0598	CbGbCtD
Benzatropine—Ileus paralytic—Vinblastine—kidney cancer	0.0139	0.0413	CcSEcCtD
Benzatropine—Ileus paralytic—Vincristine—kidney cancer	0.00977	0.029	CcSEcCtD
Benzatropine—Ileus—Vinblastine—kidney cancer	0.00848	0.0252	CcSEcCtD
Benzatropine—Ileus—Everolimus—kidney cancer	0.00845	0.0251	CcSEcCtD
Benzatropine—Ileus—Erlotinib—kidney cancer	0.00815	0.0242	CcSEcCtD
Benzatropine—Ileus paralytic—Paclitaxel—kidney cancer	0.00776	0.0231	CcSEcCtD
Benzatropine—Ileus paralytic—Capecitabine—kidney cancer	0.00637	0.0189	CcSEcCtD
Benzatropine—Ileus—Vincristine—kidney cancer	0.00597	0.0177	CcSEcCtD
Benzatropine—Cerebrovascular accident—Pazopanib—kidney cancer	0.00561	0.0167	CcSEcCtD
Benzatropine—Dysphagia—Temsirolimus—kidney cancer	0.00504	0.015	CcSEcCtD
Benzatropine—Ileus—Paclitaxel—kidney cancer	0.00474	0.0141	CcSEcCtD
Benzatropine—Dysuria—Temsirolimus—kidney cancer	0.00472	0.014	CcSEcCtD
Benzatropine—Cerebrovascular accident—Vinblastine—kidney cancer	0.00445	0.0132	CcSEcCtD
Benzatropine—Cerebrovascular accident—Erlotinib—kidney cancer	0.00427	0.0127	CcSEcCtD
Benzatropine—Urinary retention—Everolimus—kidney cancer	0.00413	0.0123	CcSEcCtD
Benzatropine—Ileus—Capecitabine—kidney cancer	0.00389	0.0116	CcSEcCtD
Benzatropine—Hypoaesthesia—Pazopanib—kidney cancer	0.00378	0.0112	CcSEcCtD
Benzatropine—Dysphagia—Everolimus—kidney cancer	0.00375	0.0112	CcSEcCtD
Benzatropine—Cerebrovascular accident—Sunitinib—kidney cancer	0.0037	0.011	CcSEcCtD
Benzatropine—Dysphagia—Erlotinib—kidney cancer	0.00362	0.0108	CcSEcCtD
Benzatropine—Memory impairment—Capecitabine—kidney cancer	0.00351	0.0104	CcSEcCtD
Benzatropine—Dysuria—Everolimus—kidney cancer	0.00351	0.0104	CcSEcCtD
Benzatropine—Dysphagia—Sorafenib—kidney cancer	0.00326	0.00968	CcSEcCtD
Benzatropine—Dysphagia—Sunitinib—kidney cancer	0.00313	0.00931	CcSEcCtD
Benzatropine—Vision blurred—Pazopanib—kidney cancer	0.00312	0.00927	CcSEcCtD
Benzatropine—Hypoaesthesia—Vinblastine—kidney cancer	0.003	0.00892	CcSEcCtD
Benzatropine—Hypoaesthesia—Everolimus—kidney cancer	0.00299	0.00888	CcSEcCtD
Benzatropine—Cerebrovascular accident—Gemcitabine—kidney cancer	0.00297	0.00882	CcSEcCtD
Benzatropine—Dysphagia—Dactinomycin—kidney cancer	0.00297	0.00882	CcSEcCtD
Benzatropine—Urinary retention—Vincristine—kidney cancer	0.00292	0.00867	CcSEcCtD
Benzatropine—Dry mouth—Pazopanib—kidney cancer	0.00276	0.00819	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—kidney cancer	0.00251	0.00745	CcSEcCtD
Benzatropine—Hypoaesthesia—Sunitinib—kidney cancer	0.0025	0.00742	CcSEcCtD
Benzatropine—Decreased appetite—Temsirolimus—kidney cancer	0.00249	0.00741	CcSEcCtD
Benzatropine—Cerebrovascular accident—Paclitaxel—kidney cancer	0.00249	0.00739	CcSEcCtD
Benzatropine—Dysuria—Vincristine—kidney cancer	0.00248	0.00737	CcSEcCtD
Benzatropine—Vision blurred—Everolimus—kidney cancer	0.00246	0.00732	CcSEcCtD
Benzatropine—Constipation—Temsirolimus—kidney cancer	0.00245	0.00729	CcSEcCtD
Benzatropine—Decreased appetite—Pazopanib—kidney cancer	0.00235	0.00698	CcSEcCtD
Benzatropine—Body temperature increased—Temsirolimus—kidney cancer	0.00227	0.00674	CcSEcCtD
Benzatropine—Dry mouth—Everolimus—kidney cancer	0.00218	0.00647	CcSEcCtD
Benzatropine—Hypersensitivity—Temsirolimus—kidney cancer	0.00211	0.00628	CcSEcCtD
Benzatropine—Hypoaesthesia—Vincristine—kidney cancer	0.00211	0.00627	CcSEcCtD
Benzatropine—Dysphagia—Paclitaxel—kidney cancer	0.0021	0.00626	CcSEcCtD
Benzatropine—Tachycardia—Everolimus—kidney cancer	0.00208	0.00619	CcSEcCtD
Benzatropine—Trimethaphan—BCHE—kidney cancer	0.00207	0.457	CrCbGaD
Benzatropine—Cerebrovascular accident—Capecitabine—kidney cancer	0.00204	0.00606	CcSEcCtD
Benzatropine—Dysuria—Paclitaxel—kidney cancer	0.00197	0.00585	CcSEcCtD
Benzatropine—Urinary retention—Capecitabine—kidney cancer	0.0019	0.00565	CcSEcCtD
Benzatropine—Dry mouth—Sorafenib—kidney cancer	0.00189	0.00562	CcSEcCtD
Benzatropine—Decreased appetite—Vinblastine—kidney cancer	0.00186	0.00553	CcSEcCtD
Benzatropine—Decreased appetite—Everolimus—kidney cancer	0.00185	0.00551	CcSEcCtD
Benzatropine—Constipation—Vinblastine—kidney cancer	0.00183	0.00544	CcSEcCtD
Benzatropine—Constipation—Everolimus—kidney cancer	0.00182	0.00542	CcSEcCtD
Benzatropine—Vomiting—Temsirolimus—kidney cancer	0.00182	0.00542	CcSEcCtD
Benzatropine—Dry mouth—Sunitinib—kidney cancer	0.00182	0.0054	CcSEcCtD
Benzatropine—Rash—Temsirolimus—kidney cancer	0.00181	0.00538	CcSEcCtD
Benzatropine—Dermatitis—Temsirolimus—kidney cancer	0.00181	0.00537	CcSEcCtD
Benzatropine—Decreased appetite—Erlotinib—kidney cancer	0.00179	0.00532	CcSEcCtD
Benzatropine—Feeling abnormal—Vinblastine—kidney cancer	0.00176	0.00525	CcSEcCtD
Benzatropine—Constipation—Erlotinib—kidney cancer	0.00176	0.00523	CcSEcCtD
Benzatropine—Feeling abnormal—Everolimus—kidney cancer	0.00176	0.00523	CcSEcCtD
Benzatropine—Dysphagia—Capecitabine—kidney cancer	0.00173	0.00514	CcSEcCtD
Benzatropine—Vomiting—Pazopanib—kidney cancer	0.00172	0.00511	CcSEcCtD
Benzatropine—Rash—Pazopanib—kidney cancer	0.0017	0.00506	CcSEcCtD
Benzatropine—Nausea—Temsirolimus—kidney cancer	0.0017	0.00506	CcSEcCtD
Benzatropine—Dermatitis—Pazopanib—kidney cancer	0.0017	0.00506	CcSEcCtD
Benzatropine—Body temperature increased—Everolimus—kidney cancer	0.00169	0.00501	CcSEcCtD
Benzatropine—Hypoaesthesia—Paclitaxel—kidney cancer	0.00168	0.00498	CcSEcCtD
Benzatropine—Body temperature increased—Erlotinib—kidney cancer	0.00163	0.00484	CcSEcCtD
Benzatropine—Dysuria—Capecitabine—kidney cancer	0.00162	0.0048	CcSEcCtD
Benzatropine—Decreased appetite—Sorafenib—kidney cancer	0.00161	0.00479	CcSEcCtD
Benzatropine—Nausea—Pazopanib—kidney cancer	0.0016	0.00477	CcSEcCtD
Benzatropine—Constipation—Sorafenib—kidney cancer	0.00158	0.00471	CcSEcCtD
Benzatropine—Hypersensitivity—Vinblastine—kidney cancer	0.00158	0.00469	CcSEcCtD
Benzatropine—Hypersensitivity—Everolimus—kidney cancer	0.00157	0.00467	CcSEcCtD
Benzatropine—Decreased appetite—Sunitinib—kidney cancer	0.00155	0.0046	CcSEcCtD
Benzatropine—Constipation—Sunitinib—kidney cancer	0.00152	0.00453	CcSEcCtD
Benzatropine—Decreased appetite—Dactinomycin—kidney cancer	0.00147	0.00436	CcSEcCtD
Benzatropine—Body temperature increased—Sorafenib—kidney cancer	0.00146	0.00435	CcSEcCtD
Benzatropine—Tension—Paclitaxel—kidney cancer	0.00144	0.00428	CcSEcCtD
Benzatropine—Nervousness—Paclitaxel—kidney cancer	0.00142	0.00423	CcSEcCtD
Benzatropine—Body temperature increased—Sunitinib—kidney cancer	0.00141	0.00419	CcSEcCtD
Benzatropine—Feeling abnormal—Dactinomycin—kidney cancer	0.00139	0.00413	CcSEcCtD
Benzatropine—Vision blurred—Paclitaxel—kidney cancer	0.00138	0.00411	CcSEcCtD
Benzatropine—Hypoaesthesia—Capecitabine—kidney cancer	0.00138	0.00409	CcSEcCtD
Benzatropine—Hypersensitivity—Sorafenib—kidney cancer	0.00136	0.00406	CcSEcCtD
Benzatropine—Vomiting—Vinblastine—kidney cancer	0.00136	0.00405	CcSEcCtD
Benzatropine—Vomiting—Everolimus—kidney cancer	0.00136	0.00403	CcSEcCtD
Benzatropine—Rash—Everolimus—kidney cancer	0.00135	0.004	CcSEcCtD
Benzatropine—Dermatitis—Everolimus—kidney cancer	0.00134	0.00399	CcSEcCtD
Benzatropine—Body temperature increased—Dactinomycin—kidney cancer	0.00133	0.00396	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.00131	0.00391	CcSEcCtD
Benzatropine—Hypersensitivity—Sunitinib—kidney cancer	0.00131	0.0039	CcSEcCtD
Benzatropine—Decreased appetite—Vincristine—kidney cancer	0.00131	0.00389	CcSEcCtD
Benzatropine—Vomiting—Erlotinib—kidney cancer	0.00131	0.00389	CcSEcCtD
Benzatropine—Rash—Erlotinib—kidney cancer	0.0013	0.00386	CcSEcCtD
Benzatropine—Dermatitis—Erlotinib—kidney cancer	0.0013	0.00385	CcSEcCtD
Benzatropine—Constipation—Vincristine—kidney cancer	0.00129	0.00383	CcSEcCtD
Benzatropine—Nausea—Vinblastine—kidney cancer	0.00127	0.00378	CcSEcCtD
Benzatropine—Nausea—Everolimus—kidney cancer	0.00127	0.00377	CcSEcCtD
Benzatropine—Decreased appetite—Gemcitabine—kidney cancer	0.00124	0.00369	CcSEcCtD
Benzatropine—Hypersensitivity—Dactinomycin—kidney cancer	0.00124	0.00369	CcSEcCtD
Benzatropine—Constipation—Gemcitabine—kidney cancer	0.00122	0.00363	CcSEcCtD
Benzatropine—Nausea—Erlotinib—kidney cancer	0.00122	0.00363	CcSEcCtD
Benzatropine—Dry mouth—Paclitaxel—kidney cancer	0.00122	0.00363	CcSEcCtD
Benzatropine—Confusional state—Paclitaxel—kidney cancer	0.00121	0.00359	CcSEcCtD
Benzatropine—Body temperature increased—Vincristine—kidney cancer	0.00119	0.00354	CcSEcCtD
Benzatropine—Feeling abnormal—Gemcitabine—kidney cancer	0.00118	0.0035	CcSEcCtD
Benzatropine—Vomiting—Sorafenib—kidney cancer	0.00118	0.0035	CcSEcCtD
Benzatropine—Tachycardia—Paclitaxel—kidney cancer	0.00117	0.00347	CcSEcCtD
Benzatropine—Rash—Sorafenib—kidney cancer	0.00117	0.00347	CcSEcCtD
Benzatropine—Dermatitis—Sorafenib—kidney cancer	0.00117	0.00347	CcSEcCtD
Benzatropine—Vision blurred—Capecitabine—kidney cancer	0.00113	0.00337	CcSEcCtD
Benzatropine—Vomiting—Sunitinib—kidney cancer	0.00113	0.00337	CcSEcCtD
Benzatropine—Body temperature increased—Gemcitabine—kidney cancer	0.00113	0.00336	CcSEcCtD
Benzatropine—Rash—Sunitinib—kidney cancer	0.00112	0.00334	CcSEcCtD
Benzatropine—Dermatitis—Sunitinib—kidney cancer	0.00112	0.00334	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—kidney cancer	0.00111	0.00331	CcSEcCtD
Benzatropine—Hypersensitivity—Vincristine—kidney cancer	0.00111	0.0033	CcSEcCtD
Benzatropine—Nausea—Sorafenib—kidney cancer	0.0011	0.00327	CcSEcCtD
Benzatropine—Vomiting—Dactinomycin—kidney cancer	0.00107	0.00319	CcSEcCtD
Benzatropine—Rash—Dactinomycin—kidney cancer	0.00106	0.00316	CcSEcCtD
Benzatropine—Nausea—Sunitinib—kidney cancer	0.00106	0.00315	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—kidney cancer	0.00104	0.0031	CcSEcCtD
Benzatropine—Decreased appetite—Paclitaxel—kidney cancer	0.00104	0.00309	CcSEcCtD
Benzatropine—Constipation—Paclitaxel—kidney cancer	0.00102	0.00304	CcSEcCtD
Benzatropine—Dry mouth—Capecitabine—kidney cancer	0.001	0.00298	CcSEcCtD
Benzatropine—Nausea—Dactinomycin—kidney cancer	0.001	0.00298	CcSEcCtD
Benzatropine—Confusional state—Capecitabine—kidney cancer	0.00099	0.00294	CcSEcCtD
Benzatropine—Feeling abnormal—Paclitaxel—kidney cancer	0.000986	0.00293	CcSEcCtD
Benzatropine—Tachycardia—Capecitabine—kidney cancer	0.000959	0.00285	CcSEcCtD
Benzatropine—Vomiting—Vincristine—kidney cancer	0.000958	0.00285	CcSEcCtD
Benzatropine—Rash—Vincristine—kidney cancer	0.00095	0.00282	CcSEcCtD
Benzatropine—Dermatitis—Vincristine—kidney cancer	0.000949	0.00282	CcSEcCtD
Benzatropine—Body temperature increased—Paclitaxel—kidney cancer	0.000946	0.00281	CcSEcCtD
Benzatropine—Vomiting—Gemcitabine—kidney cancer	0.000909	0.0027	CcSEcCtD
Benzatropine—Rash—Gemcitabine—kidney cancer	0.000901	0.00268	CcSEcCtD
Benzatropine—Dermatitis—Gemcitabine—kidney cancer	0.000901	0.00268	CcSEcCtD
Benzatropine—Nausea—Vincristine—kidney cancer	0.000895	0.00266	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000887	0.00264	CcSEcCtD
Benzatropine—Hypersensitivity—Paclitaxel—kidney cancer	0.000882	0.00262	CcSEcCtD
Benzatropine—Decreased appetite—Capecitabine—kidney cancer	0.000854	0.00254	CcSEcCtD
Benzatropine—Nausea—Gemcitabine—kidney cancer	0.000849	0.00252	CcSEcCtD
Benzatropine—Constipation—Capecitabine—kidney cancer	0.00084	0.0025	CcSEcCtD
Benzatropine—Reboxetine—ABCB1—kidney cancer	0.000826	0.182	CrCbGaD
Benzatropine—Feeling abnormal—Capecitabine—kidney cancer	0.000809	0.00241	CcSEcCtD
Benzatropine—Body temperature increased—Capecitabine—kidney cancer	0.000777	0.00231	CcSEcCtD
Benzatropine—Tension—Doxorubicin—kidney cancer	0.000761	0.00226	CcSEcCtD
Benzatropine—Vomiting—Paclitaxel—kidney cancer	0.000761	0.00226	CcSEcCtD
Benzatropine—Rash—Paclitaxel—kidney cancer	0.000755	0.00224	CcSEcCtD
Benzatropine—Dermatitis—Paclitaxel—kidney cancer	0.000754	0.00224	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—kidney cancer	0.000754	0.00224	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—kidney cancer	0.000731	0.00217	CcSEcCtD
Benzatropine—Hypersensitivity—Capecitabine—kidney cancer	0.000724	0.00215	CcSEcCtD
Benzatropine—Nausea—Paclitaxel—kidney cancer	0.000711	0.00211	CcSEcCtD
Benzatropine—Cinnarizine—CYP1A1—kidney cancer	0.000704	0.155	CrCbGaD
Benzatropine—Dry mouth—Doxorubicin—kidney cancer	0.000646	0.00192	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—kidney cancer	0.000638	0.0019	CcSEcCtD
Benzatropine—Vomiting—Capecitabine—kidney cancer	0.000625	0.00186	CcSEcCtD
Benzatropine—Rash—Capecitabine—kidney cancer	0.000619	0.00184	CcSEcCtD
Benzatropine—Dermatitis—Capecitabine—kidney cancer	0.000619	0.00184	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—kidney cancer	0.000618	0.00184	CcSEcCtD
Benzatropine—Nausea—Capecitabine—kidney cancer	0.000583	0.00173	CcSEcCtD
Benzatropine—Diphenhydramine—PTGS1—kidney cancer	0.000553	0.122	CrCbGaD
Benzatropine—Decreased appetite—Doxorubicin—kidney cancer	0.00055	0.00164	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—kidney cancer	0.000541	0.00161	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—kidney cancer	0.000522	0.00155	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—kidney cancer	0.000501	0.00149	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—kidney cancer	0.000467	0.00139	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—kidney cancer	0.000403	0.0012	CcSEcCtD
Benzatropine—Rash—Doxorubicin—kidney cancer	0.000399	0.00119	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—kidney cancer	0.000399	0.00119	CcSEcCtD
Benzatropine—Fentanyl—ABCB1—kidney cancer	0.000378	0.0835	CrCbGaD
Benzatropine—Nausea—Doxorubicin—kidney cancer	0.000376	0.00112	CcSEcCtD
Benzatropine—CHRM2—Signaling by GPCR—ITPR2—kidney cancer	3.41e-05	0.00103	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CCBL1—kidney cancer	3.29e-05	0.000994	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.24e-05	0.000977	CbGpPWpGaD
Benzatropine—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	3.22e-05	0.000973	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—ANXA1—kidney cancer	3.2e-05	0.000965	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—ANXA1—kidney cancer	3.19e-05	0.000962	CbGpPWpGaD
Benzatropine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	3.18e-05	0.000961	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—ANXA1—kidney cancer	3.15e-05	0.00095	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PPAT—kidney cancer	3.1e-05	0.000937	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GLIPR1—kidney cancer	3.1e-05	0.000937	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.06e-05	0.000925	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.03e-05	0.000916	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—SFRP2—kidney cancer	2.99e-05	0.000901	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—SFRP2—kidney cancer	2.98e-05	0.000898	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—SFRP2—kidney cancer	2.94e-05	0.000887	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.92e-05	0.000882	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.91e-05	0.000879	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—ANXA1—kidney cancer	2.9e-05	0.000876	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—ANXA1—kidney cancer	2.89e-05	0.000874	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—FH—kidney cancer	2.88e-05	0.000871	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—APRT—kidney cancer	2.88e-05	0.000871	CbGpPWpGaD
Benzatropine—SLC6A3—Neuronal System—MAPK1—kidney cancer	2.86e-05	0.000864	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—ANXA1—kidney cancer	2.86e-05	0.000862	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.85e-05	0.000862	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PPAT—kidney cancer	2.85e-05	0.000862	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.82e-05	0.000851	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.78e-05	0.000839	CbGpPWpGaD
Benzatropine—HRH1—GPCR ligand binding—POMC—kidney cancer	2.77e-05	0.000837	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.77e-05	0.000836	CbGpPWpGaD
Benzatropine—CHRM1—GPCR ligand binding—POMC—kidney cancer	2.76e-05	0.000834	CbGpPWpGaD
Benzatropine—CHRM2—GPCR ligand binding—POMC—kidney cancer	2.73e-05	0.000823	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GPC3—kidney cancer	2.71e-05	0.000819	CbGpPWpGaD
Benzatropine—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	2.7e-05	0.000814	CbGpPWpGaD
Benzatropine—CHRM1—G alpha (q) signalling events—PIK3CA—kidney cancer	2.69e-05	0.000811	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—APRT—kidney cancer	2.65e-05	0.000801	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—FH—kidney cancer	2.65e-05	0.000801	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CA2—kidney cancer	2.64e-05	0.000797	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.62e-05	0.000792	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.62e-05	0.00079	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALAD—kidney cancer	2.57e-05	0.000776	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.51e-05	0.000758	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GPC3—kidney cancer	2.49e-05	0.000753	CbGpPWpGaD
Benzatropine—CHRM1—Circadian rythm related genes—TP53—kidney cancer	2.45e-05	0.000741	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.45e-05	0.000741	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CA2—kidney cancer	2.43e-05	0.000733	CbGpPWpGaD
Benzatropine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.41e-05	0.000728	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—AKAP13—kidney cancer	2.41e-05	0.000727	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CASP2—kidney cancer	2.41e-05	0.000727	CbGpPWpGaD
Benzatropine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	2.4e-05	0.000726	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CASP2—kidney cancer	2.4e-05	0.000724	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—AKAP13—kidney cancer	2.4e-05	0.000724	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—AKAP13—kidney cancer	2.37e-05	0.000715	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CASP2—kidney cancer	2.37e-05	0.000715	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALAD—kidney cancer	2.36e-05	0.000714	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PGK1—kidney cancer	2.35e-05	0.00071	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.35e-05	0.00071	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.000697	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—LDHB—kidney cancer	2.31e-05	0.000696	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.000681	CbGpPWpGaD
Benzatropine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.24e-05	0.000677	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—GRB7—kidney cancer	2.2e-05	0.000665	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—GRB7—kidney cancer	2.19e-05	0.000662	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—GRB7—kidney cancer	2.17e-05	0.000654	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.16e-05	0.000653	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PGK1—kidney cancer	2.16e-05	0.000653	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—LDHB—kidney cancer	2.12e-05	0.00064	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ITPR2—kidney cancer	2.05e-05	0.000618	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ITPR2—kidney cancer	2.04e-05	0.000616	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ITPR2—kidney cancer	2.01e-05	0.000608	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CA9—kidney cancer	2e-05	0.000604	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.95e-05	0.00059	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	1.85e-05	0.00056	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CTNNA1—kidney cancer	1.85e-05	0.000558	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	1.84e-05	0.000557	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HSPB1—kidney cancer	1.84e-05	0.000557	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CA9—kidney cancer	1.84e-05	0.000555	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HSPB1—kidney cancer	1.84e-05	0.000555	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—EIF4EBP1—kidney cancer	1.84e-05	0.000555	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.83e-05	0.000551	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.81e-05	0.000548	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.81e-05	0.000548	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TSC1—kidney cancer	1.71e-05	0.000518	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ANXA1—kidney cancer	1.71e-05	0.000518	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PSMD7—kidney cancer	1.71e-05	0.000518	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PSMD7—kidney cancer	1.71e-05	0.000516	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TSC1—kidney cancer	1.71e-05	0.000516	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ANXA1—kidney cancer	1.71e-05	0.000516	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CRABP1—kidney cancer	1.7e-05	0.000513	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.69e-05	0.000509	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.69e-05	0.000509	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.69e-05	0.000509	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—FLT1—kidney cancer	1.66e-05	0.000501	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—FLT1—kidney cancer	1.66e-05	0.0005	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.63e-05	0.000493	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ITPR2—kidney cancer	1.58e-05	0.000477	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—POMC—kidney cancer	1.57e-05	0.000473	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.56e-05	0.000472	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—POMC—kidney cancer	1.56e-05	0.000471	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.54e-05	0.000465	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PAK1—kidney cancer	1.54e-05	0.000465	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JUNB—kidney cancer	1.54e-05	0.000465	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JUNB—kidney cancer	1.53e-05	0.000463	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PAK1—kidney cancer	1.53e-05	0.000463	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.51e-05	0.000457	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.51e-05	0.000457	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.46e-05	0.00044	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.45e-05	0.000439	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ACHE—kidney cancer	1.44e-05	0.000435	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTT1—kidney cancer	1.44e-05	0.000435	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—POMC—kidney cancer	1.42e-05	0.000429	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—POMC—kidney cancer	1.42e-05	0.000428	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.4e-05	0.000422	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SCARB1—kidney cancer	1.36e-05	0.000412	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS1—kidney cancer	1.35e-05	0.000408	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ACHE—kidney cancer	1.33e-05	0.0004	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.33e-05	0.0004	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PSMD7—kidney cancer	1.32e-05	0.0004	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF2—kidney cancer	1.26e-05	0.00038	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—BCHE—kidney cancer	1.26e-05	0.000379	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.25e-05	0.000379	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF2—kidney cancer	1.25e-05	0.000379	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	1.25e-05	0.000378	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN2B—kidney cancer	1.25e-05	0.000377	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.24e-05	0.000375	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.24e-05	0.000374	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF2—kidney cancer	1.24e-05	0.000374	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	1.23e-05	0.000372	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000368	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IGF1R—kidney cancer	1.22e-05	0.000367	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IGF1R—kidney cancer	1.21e-05	0.000366	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.2e-05	0.000362	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	1.2e-05	0.000361	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—RAF1—kidney cancer	1.17e-05	0.000354	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—RAF1—kidney cancer	1.17e-05	0.000353	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.16e-05	0.000351	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—IL2—kidney cancer	1.16e-05	0.00035	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—BCHE—kidney cancer	1.15e-05	0.000349	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—IL2—kidney cancer	1.15e-05	0.000348	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	1.15e-05	0.000348	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000344	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	1.14e-05	0.000344	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000333	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—IL2—kidney cancer	1.05e-05	0.000317	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—IL2—kidney cancer	1.05e-05	0.000316	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—IL2—kidney cancer	1.03e-05	0.000312	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.01e-05	0.000306	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—HIF1A—kidney cancer	1e-05	0.000302	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TSC2—kidney cancer	9.99e-06	0.000302	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTP1—kidney cancer	9.99e-06	0.000302	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—HIF1A—kidney cancer	9.98e-06	0.000301	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TSC2—kidney cancer	9.96e-06	0.000301	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	9.86e-06	0.000298	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TSC2—kidney cancer	9.83e-06	0.000297	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KDR—kidney cancer	9.58e-06	0.000289	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KDR—kidney cancer	9.55e-06	0.000288	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—ABCB1—kidney cancer	9.46e-06	0.000286	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KDR—kidney cancer	9.43e-06	0.000285	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTP1—kidney cancer	9.19e-06	0.000277	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—GSTM1—kidney cancer	9.18e-06	0.000277	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—APC—kidney cancer	8.82e-06	0.000266	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KIT—kidney cancer	8.82e-06	0.000266	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KIT—kidney cancer	8.8e-06	0.000266	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—APC—kidney cancer	8.8e-06	0.000266	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.7e-06	0.000263	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—ABCB1—kidney cancer	8.7e-06	0.000263	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—APC—kidney cancer	8.68e-06	0.000262	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KIT—kidney cancer	8.68e-06	0.000262	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	8.45e-06	0.000255	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—GSTM1—kidney cancer	8.44e-06	0.000255	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK3—kidney cancer	8.42e-06	0.000254	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—POMC—kidney cancer	8.4e-06	0.000254	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—POMC—kidney cancer	8.37e-06	0.000253	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	8.32e-06	0.000251	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—BRAF—kidney cancer	8.3e-06	0.00025	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—BRAF—kidney cancer	8.27e-06	0.00025	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—POMC—kidney cancer	8.27e-06	0.00025	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—BRAF—kidney cancer	8.16e-06	0.000246	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	8.04e-06	0.000243	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—MAPK1—kidney cancer	8.02e-06	0.000242	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.01e-06	0.000242	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	7.91e-06	0.000239	CbGpPWpGaD
Benzatropine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	7.68e-06	0.000232	CbGpPWpGaD
Benzatropine—CHRM1—GPCR downstream signaling—PIK3CA—kidney cancer	7.66e-06	0.000231	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—KRAS—kidney cancer	7.6e-06	0.000229	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—KRAS—kidney cancer	7.57e-06	0.000229	CbGpPWpGaD
Benzatropine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	7.56e-06	0.000228	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	7.47e-06	0.000226	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.15e-06	0.000216	CbGpPWpGaD
Benzatropine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	6.98e-06	0.000211	CbGpPWpGaD
Benzatropine—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	6.96e-06	0.00021	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RAF1—kidney cancer	6.93e-06	0.000209	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RAF1—kidney cancer	6.9e-06	0.000208	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—RELA—kidney cancer	6.9e-06	0.000208	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—RELA—kidney cancer	6.87e-06	0.000208	CbGpPWpGaD
Benzatropine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	6.87e-06	0.000207	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—ERBB2—kidney cancer	6.85e-06	0.000207	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	6.83e-06	0.000206	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RAF1—kidney cancer	6.82e-06	0.000206	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—RELA—kidney cancer	6.78e-06	0.000205	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MTOR—kidney cancer	6.76e-06	0.000204	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	6.74e-06	0.000204	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MTOR—kidney cancer	6.74e-06	0.000204	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MTOR—kidney cancer	6.65e-06	0.000201	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—POMC—kidney cancer	6.49e-06	0.000196	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	6.35e-06	0.000192	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	6.33e-06	0.000191	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	6.24e-06	0.000189	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—IL2—kidney cancer	6.21e-06	0.000188	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—IL2—kidney cancer	6.19e-06	0.000187	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—IL2—kidney cancer	6.11e-06	0.000184	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CCND1—kidney cancer	6.05e-06	0.000183	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—JUN—kidney cancer	6.04e-06	0.000182	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CCND1—kidney cancer	6.03e-06	0.000182	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—JUN—kidney cancer	6.02e-06	0.000182	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	6e-06	0.000181	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	5.98e-06	0.00018	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—POMC—kidney cancer	5.97e-06	0.00018	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CCND1—kidney cancer	5.96e-06	0.00018	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—JUN—kidney cancer	5.94e-06	0.000179	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	5.9e-06	0.000178	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PTEN—kidney cancer	5.84e-06	0.000176	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PTEN—kidney cancer	5.82e-06	0.000176	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PTEN—kidney cancer	5.75e-06	0.000174	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—VEGFA—kidney cancer	5.28e-06	0.000159	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	5.26e-06	0.000159	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	5.19e-06	0.000157	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTGS2—kidney cancer	5.18e-06	0.000156	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK3—kidney cancer	4.99e-06	0.000151	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	4.98e-06	0.00015	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	4.91e-06	0.000148	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MYC—kidney cancer	4.86e-06	0.000147	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MYC—kidney cancer	4.84e-06	0.000146	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MYC—kidney cancer	4.78e-06	0.000144	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTGS2—kidney cancer	4.76e-06	0.000144	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—MAPK1—kidney cancer	4.75e-06	0.000143	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	4.74e-06	0.000143	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	4.67e-06	0.000141	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PTEN—kidney cancer	4.51e-06	0.000136	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—KRAS—kidney cancer	4.49e-06	0.000135	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—KRAS—kidney cancer	4.47e-06	0.000135	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—KRAS—kidney cancer	4.41e-06	0.000133	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PTEN—kidney cancer	4.15e-06	0.000125	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	4.12e-06	0.000124	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	4.11e-06	0.000124	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	4.06e-06	0.000122	CbGpPWpGaD
Benzatropine—HRH1—Signaling Pathways—TP53—kidney cancer	3.99e-06	0.00012	CbGpPWpGaD
Benzatropine—CHRM1—Signaling Pathways—TP53—kidney cancer	3.98e-06	0.00012	CbGpPWpGaD
Benzatropine—CHRM2—Signaling Pathways—TP53—kidney cancer	3.92e-06	0.000118	CbGpPWpGaD
Benzatropine—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.18e-06	9.61e-05	CbGpPWpGaD
Benzatropine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.93e-06	8.84e-05	CbGpPWpGaD
